Martha Lundberg
Martha S. Lundberg, Ph.D.
Program Director, Tissue Engineering and Regenerative Medicine
Contracting Officer's Representative,
Production Assistance for Cellular Therapies,
Division of Cardiovascular Sciences,
National Heart, Lung, and Blood Institute,
6701 Rockledge Drive, Rm 8210, Bethesda, MD 20892-7940
Office: 301-435-0576; Cell: 240-426-7441


Dr. Martha Lundberg is a Program Director in the Advanced Technologies and Surgery Branch at the National Heart, Lung, and Blood Institute (NHLBI). She brings more than 17 years of experience and exemplary management of human cell-based systems for cardiovascular regenerative medicine, smart polymer systems and biodegradable matrices, and technologies for tissue engineered blood vessels, heart valves and cardiac patches. Martha has proven success in building solid, trusting relationships with key stakeholders to stimulate innovative NHLBI investment in over a dozen research programs. She represents the NHLBI and the NIH at Congressional meetings, National and International scientific conferences, and other Trans-governmental activities, such as the Multi-Agency Tissue Engineering Science Working Group and the National Academies' Regenerative Medicine Forum. Martha received her second NIH Director's Award in 2015 for her work with the NIH Tissue Chip Consortium.


Driving Medical Innovation through Biofabrication

Indications for cell therapy in medicine are driving the need for translational research and early phase clinical trials. Academic and industry partnerships are becoming more commonplace in managing the pace of discovery with the cost of approved therapies. In this presentation, aspects of the successful relationship between academia and industry to support clinical research will be discussed using specific examples of cell and tissue biofabrication and biomanufacturing.
  • DAYS
Key Dates

  Abstract continue accepting
Deadline for early registration
  September 15, 2017